Metabolic Regulation of Natural Killer Cell Activation
自然杀伤细胞激活的代谢调节
基本信息
- 批准号:10789052
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-05 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activated Natural Killer CellAcuteAdoptive TransferAffectAgonistAntibodiesCell Differentiation processCell MaturationCell physiologyCellsCitratesClinical TrialsDataDefectDependenceDiseaseEffector CellEnvironmentFRAP1 geneGenetic ModelsGenetic TranscriptionGlucoseGlycolysisGoalsHealthHerpesviridae InfectionsHomeostasisHumanImmuneImmunityImmunologic SurveillanceImmunotherapyIn VitroInfectionInflammatoryInterferon Type IIInterleukin-15KnowledgeLigandsLymphocyteMalatesMediatingMetabolicMetabolic PathwayMetabolic stressMetabolismModelingNK Cell ActivationNK cell therapyNatural Killer CellsOxidative PhosphorylationPathway interactionsPatientsPlayProcessProductionRecurrenceRegulationResearchRoleTestingTranscriptTranscriptional RegulationUp-RegulationViralVirusVirus Diseasesc-myc Genescancer cellcell killingcytokineflexibilityglucose metabolismhuman diseaseimprovedin vivoin vivo evaluationinhibitorinterestmTOR inhibitionmetabolomicsneoplastic cellreceptorresponsetranscription factortumorvirus related cancer
项目摘要
Project Summary
The long-term goal of this project is to determine the metabolic regulation of NK cell effector functions to
improve our understanding of basic mechanisms of NK cell activation in health and disease. Natural killer (NK)
cells are innate immune lymphocytes that serve as a critical first line defense against infection, particularly
viruses, and are important for tumor immunosurveillance. NK cells mediate their effects via two mechanisms:
production of cytokines (especially IFN-gamma) and target cell killing. NK cell effector functions can be
triggered by inflammatory cytokines or engagement of germline-encoded activating receptors whose ligands
are displayed by infected and/or tumor cells. Metabolic regulation plays a key role in many aspects of
immunity, including in NK cell response to viral infection. We previously demonstrated that stimulation of
naïve, fresh NK cells through cytokines versus activating receptors has differential metabolic requirements,
with activating receptor stimulation exquisitely sensitive to inhibition of glucose-driven oxidative
phosphorylation (OXPHOS). IL-15 priming of NK cells can overcome metabolic requirements for NK cell
effector functions in vitro and in vivo, leading to metabolic flexibility evident as the ability to efficiently function
in the face of inhibition of key metabolic pathways. Our preliminary studies demonstrate activation-dependent
differences in the metabolic fuels and pathways required for NK cell effector functions in vitro and in vivo that
change with cytokine priming. We are interested in how cytokine priming leads to this metabolic `flexibility', with
a long-term goal of applying this knowledge to strategies for NK cell therapies. This proposal presents a 5 year
plan to investigate the metabolic regulation of NK cell activation. The specific aims of this proposal are to
investigate: 1) metabolic pathways upregulated during cytokine priming and the effects of glucose metabolism,
2) transcription factors regulating production of cytokine transcript in primed NK cells, and 3) metabolic
flexibility dependent on mTOR. We will use new inducible models with NK-specific deletion of key regulators of
metabolic pathways to rigorously test our hypotheses. The studies proposed here will advance our
understanding of how NK cells can be primed for metabolic flexibility and metabolic mechanisms important for
NK cell effector function, with a long-term goal of optimizing strategies to target NK cells for therapy of human
disease.
项目摘要
该项目的长期目标是确定NK细胞效应子功能的代谢调节
提高我们对健康和疾病中NK细胞激活的基本机制的理解。天然杀手(NK)
细胞是先天免疫淋巴细胞,是针对感染的关键第一线防御
病毒,对于肿瘤免疫监视很重要。 NK细胞通过两种机制介导其作用:
细胞因子(尤其是IFN-GAMMA)和靶细胞杀伤的产生。 NK细胞效应子功能可以是
由炎症细胞因子或种系编码的活化受体触发的,其配体
由感染和/或肿瘤细胞显示。代谢法规在许多方面起关键作用
免疫力,包括NK细胞对病毒感染的反应。我们以前证明了刺激
幼稚的,新鲜的NK细胞通过细胞因子与激活受体具有不同的代谢需求,
激活受体刺激对抑制葡萄糖驱动的氧化
磷酸化(OXPHOS)。 NK细胞的IL-15启动可以克服NK细胞的代谢需求
效应子在体外和体内功能,导致代谢灵活性证据作为有效发挥作用的能力
面对关键代谢途径的抑制。我们的初步研究表明激活依赖性
NK细胞效应子在体外和体内所需的代谢燃料和途径的差异
随着细胞因子启动的变化。我们对细胞因子启动如何导致这种代谢“灵活性”感兴趣
将这些知识应用于NK细胞疗法策略的长期目标。该提议提出了5年
计划研究NK细胞激活的代谢调节。该提议的具体目的是
研究:1)在细胞因子启动过程中上调的代谢途径和葡萄糖代谢的影响,
2)控制启动NK细胞中细胞因子转录本的转录因子和3)代谢
灵活性取决于mTOR。我们将使用新的可诱导模型以及针对NK特定删除的关键调节器的删除
代谢途径严格检验我们的假设。这里提出的研究将推动我们的
了解如何对NK细胞进行启动,以实现代谢柔韧性和代谢机制对
NK细胞效应子功能,其长期目标是优化靶向NK细胞治疗人类的策略
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MEGAN Anne COOPER其他文献
MEGAN Anne COOPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MEGAN Anne COOPER', 18)}}的其他基金
Project 1: Functional consequences of STAT3 GOF on immune cell signaling
项目 1:STAT3 GOF 对免疫细胞信号传导的功能影响
- 批准号:
10576382 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Project 1: Functional consequences of STAT3 GOF on immune cell signaling
项目 1:STAT3 GOF 对免疫细胞信号传导的功能影响
- 批准号:
10328101 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
METABOLIC REGULATION OF NATURAL KILLER CELL ACTIVATION
自然杀伤细胞激活的代谢调节
- 批准号:
9914085 - 财政年份:2017
- 资助金额:
$ 30万 - 项目类别:
METABOLIC REGULATION OF NATURAL KILLER CELL ACTIVATION
自然杀伤细胞激活的代谢调节
- 批准号:
9383758 - 财政年份:2017
- 资助金额:
$ 30万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
SPORE 德克萨斯大学 MD 安德森癌症中心 - 白血病
- 批准号:
10911713 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Viral priming and targeting NK cells against solid tumor malignancies
病毒启动和靶向 NK 细胞对抗实体瘤恶性肿瘤
- 批准号:
8952308 - 财政年份:2015
- 资助金额:
$ 30万 - 项目类别:
Viral priming and targeting NK cells against solid tumor malignancies
病毒启动和靶向 NK 细胞对抗实体瘤恶性肿瘤
- 批准号:
9120819 - 财政年份:2015
- 资助金额:
$ 30万 - 项目类别:
Understanding and manipulating the T cell contraction phase
了解和操纵 T 细胞收缩期
- 批准号:
7556348 - 财政年份:2008
- 资助金额:
$ 30万 - 项目类别:
Understanding and manipulating the T cell contraction phase
了解和操纵 T 细胞收缩期
- 批准号:
7755373 - 财政年份:2008
- 资助金额:
$ 30万 - 项目类别: